Parexel International, based in Newton, MA, is a leading Contract Research Organization (CRO) offering end-to-end solutions in biotech and therapeutic expertise for the development of life-changing medicines. With a focus on patient impact, Parexel provides services ranging from portfolio optimization and regulatory strategy to phase I-IV clinical trials and market access planning.
The company's diverse capabilities include portfolio management, early development and innovation, integrated clinical development, approval and access, value substantiation, and lifecycle management. Parexel's global reach, operational excellence, and commitment to leveraging cutting-edge technologies make them a trusted partner in advancing healthcare and improving patient outcomes.
Generated from the website